Report : Europe Blood Brain Barrier Technologies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (Bispecific Antibody RMT Approach, Trojan Horse Approach, Increasing Permeability, Passive Diffusion, and Other Non-Invasive BBB Technologies) and Application (Alzheimer’s Disease, Epilepsy, Parkinson’s Disease, Multiple Sclerosis, Hunter’s Syndrome, Brain Cancer, and Others)
Parkinson’s Disease Segment to dominate Europe Blood Brain Barrier Technologies Market during 2021–2028
According to a new market research study on “Europe Blood Brain Barrier Technologies Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Technology and Application,” is expected to reach US$ 1,548.76 million by 2028 from US$ 319.97 million in 2021. The market is estimated to grow at a CAGR of 25.3% from 2021 to 2028. The report provides trends prevailing in the Europe blood brain barrier technologies market along with the drivers and restraints pertaining to the market growth. Up-surging prevalence of neurological disorders, raising geriatric population and rising prevalence of age-associated neurological disorders, and scaling demand of nanoparticles for brain drug delivery are the major factor driving the growth of the Europe blood brain barrier technologies market. However, problems in brain medication delivery hinders the growth of Europe blood brain barrier technologies market.
The European economy is severely affected due to the exponential growth of COVID-19 cases in the region. Spain, Italy, Germany, France, and the UK are among the most affected European countries. In addition, new evidence has backed up a year-old theory that the Covid-19 infection causes neurological problems. This viewpoint initially developed in the summer of last year, during the pandemic's first wave. According to a preliminary (yet to be peer-reviewed) research by four Imperial College London academics, it is now considerably proven. Jiabin Tang, Shivani Patel, Steve Gentleman, and Paul M Matthew wrote the preprint, which indicates a "potential route" for the virus to enter the nervous system. The blood-brain barrier is a semi-permeable membrane of endothelial cells that protects the brain from the rest of the body. Monocytes, a kind of white blood cell, are activated as part of the body's defense mechanism when SARS-CoV-2 enters the bloodstream. To allow monocytes to cross the BBB, a complicated mechanism is activated. According to the article, "this facilitates the entry of infected and activated monocytes into the central nervous system, allowing the SARS-CoV-2 virus to pass through the loosened BBB.
The Europe blood brain barrier technologies market is segmented on the basis of technology, application, and country. Based on technology, the blood brain barrier technologies market is segmented into bispecific antibody RMT approach, trojan horse approach, increasing permeability, passive diffusion, and other non-invasive BBB technologies. In 2021, increasing permeability segment held the largest share in the market, and it is also expected to be the fastest growing segment during the forecast period. On the basis of application, the blood brain barrier technologies market is segmented into alzheimer’s disease, epilepsy, parkinson’s disease, multiple sclerosis, hunter’s syndrome, brain cancer, and others. In 2021, parkinson’s disease segment held the largest share in the market, and epilepsy is expected to be the fastest growing segment during the forecast period. Similarly, Based on country the market is segmented into Germany, UK, France, Italy, Spain, and the rest of Europe. In 2021, Germany held the largest share in the market, and the UK is expected to be the fastest growing country during the forecast period.
Teva Pharmaceutical Industries Ltd.; F. Hoffmann-La Roche Ltd.; Eli Lilly and Company; Bristol-Myers Squibb Company; Pfizer, Inc.; Johnson & Johnson Services, Inc.; Fabre-Kramer Pharmaceuticals, Inc.; Abliva AB.; and Bioasis Technologies, Inc. are among the leading companies in the Europe blood brain barrier technologies market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com